LSC - 2017 - IL-1R1 but not IL-18Rbeta or IL-18BP contribute to the beneficial effects of IL-37 on experimental asthma

M. Wegmann (Borstel, Germany)

Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Session: Asthma and allergy: from the bench to the bedside
Session type: Poster Discussion
Number: 3538
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Wegmann (Borstel, Germany). LSC - 2017 - IL-1R1 but not IL-18Rbeta or IL-18BP contribute to the beneficial effects of IL-37 on experimental asthma. 3538

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
IL-37 ameliorates experimental asthma by inhibiting IL-1
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018



LSC - 2019 - IL-4, IL-8, IL-13, IL-17, IL-33 serum levels changes in acute allergic asthma model
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019

The expression of IL17RA (the common subunit of IL-17A and IL-25 receptor) on sputum macrophages in asthma patients
Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Year: 2021



IL-33 augments rhinovirus-induced type 2 immune responses in asthma via selective upregulation of one chain of the IL-33 receptor.
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017


IL-10 and IL-1ra mediates OVA-induced Th2 airway allergic response at short and long-term
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013


AZD1402/PRS-060, an inhaled Anticalin® IL-4Ra antagonist, potently inhibits IL-4 induced functional effects in human whole blood, which can be employed translationally in clinical studies.
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018



Importin-7 knockdown reduces corticosteroid induced glucocorticoid receptor nuclear localisation and suppression of IL-1beta induced CXCL8
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013

Effectiveness of photobiomodulation on the increase of Treg cells and IL-10 cytokine in an experimental model of chronic asthma
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019


IL-9 and IL-9 receptor (IL-9r) expression in BALF lymphocytes in ILD patients: preliminary results.
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017


IL-37 requires IL18Rα and SIGIRR to diminish experimental allergic airway inflammation in mice
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

Interleukin-12 receptor mRNA expression and corticosteroid depended eosinophil apoptosis in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 223s
Year: 2003

Use of interleukin-1beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1Ra) contents in alveolar macrophages for estimation of inflammation activity in patients with different levels of asthma control
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013


ILC2 cells from severe allergic and eosinophilic asthma demonstrate increased expression of TSLP receptor (TSLPR) and enhanced proliferative capacity.
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021


LPS-induced TLR4 expression and cytokine release is impaired in monocytes and T-lymphocytes of COPD patients
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008

Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis
Source: Eur Respir J 2003; 21: 925-931
Year: 2003



Interferon-gamma (IFN-γ) alters the expression of IP-10 and IL-18 in human aveolar epithelial cells type II. Possible role in the reinforcement of Th1-dominated lung inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 521s
Year: 2001

Comparison of transcriptional differences between IL-4Ra and IL-5 blockade in a mouse model of asthma
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021

Effect of photobiomodulation on reduction of CD4STAT4 and CD4IFN-? and increased treg cells and IL-10 in an experimental model of COPD.
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019


Pro- and anti-inflammatory cytokines TNF-alpha, IFN-gamma, IL-10 and TGF-beta1 levels in blood serum as markers of plasmaferesis success and inflammation activity in lung sarcoidosis (LS)
Source: Eur Respir J 2006; 28: Suppl. 50, 676s
Year: 2006

Caspase-1 induces upstream Th2-cytokines IL-33 and TSLP and eosinophilia at viral induced asthma exacerbations
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016